MARKET

INGN

INGN

Inogen Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.91
+0.05
+0.19%
After Hours: 25.91 0 0.00% 16:01 05/27 EDT
OPEN
25.96
PREV CLOSE
25.86
HIGH
26.30
LOW
25.04
VOLUME
154.73K
TURNOVER
0
52 WEEK HIGH
82.35
52 WEEK LOW
22.51
MARKET CAP
591.68M
P/E (TTM)
-29.5675
1D
5D
1M
3M
1Y
5Y
Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning
GOLETA, Calif., May 18, 2022--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Inves...
Business Wire · 05/18 20:05
Inogen (INGN) Stock Inches Up 0.5% Post Q1 Earnings Beat
Inogen's (INGN) first-quarter results benefit from higher revenues across the majority of its geographical segments and categories.
Zacks · 05/13 14:12
Stifel Maintains Hold Rating for Inogen: Here's What You Need To Know
Stifel has decided to maintain its Hold rating of Inogen (NASDAQ:INGN) and lower its price target from $40.00 to $30.00. Shares of Inogen are trading down 4.15% over the last 24 hours, at $23.91 per share. A move to $30.00 would account for a 25.5% increas...
Benzinga · 05/09 16:00
--Stifel Adjusts Inogen's Price Target to $30 from $40, Keeps Hold Rating
MT Newswires · 05/09 13:07
--Needham Trims Inogen's Price Target to $45 From $47 on 'Lower Cash Balance,' Reiterates Buy Rating
MT Newswires · 05/06 06:48
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 20.83% and 5.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/06 00:15
Inogen Q1 Adj. EPS $0.39 Beats $(0.51) Estimate, Sales $80.40M Beat $76.55M Estimate
Inogen (NASDAQ:INGN) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $(0.51) by 176.47 percent. This is a 1400 percent increase over losses of $(0.03) per share from the same
Benzinga · 05/05 21:17
Inogen GAAP EPS of -$0.62 misses by $0.11, revenue of $80.4M beats by $3.84M
Inogen press release (NASDAQ:INGN): Q1 GAAP EPS of -$0.62 misses by $0.11. Revenue of $80.4M (-7.5% Y/Y) beats by $3.84M.
Seekingalpha · 05/05 20:21
More
No Data
Learn about the latest financial forecast of INGN. Analyze the recent business situations of Inogen Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

20.00%Strong Buy
20.00%Buy
60.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average INGN stock price target is 37.50 with a high estimate of 45.00 and a low estimate of 30.00.
High45.00
Average37.50
Low30.00
Current 25.91
EPS
Actual
Estimate
-0.68-0.34-0.010.33
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 264
Institutional Holdings: 25.20M
% Owned: 110.36%
Shares Outstanding: 22.84M
TypeInstitutionsShares
Increased
55
2.15M
New
15
197.68K
Decreased
42
716.06K
Sold Out
34
978.11K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Non-Executive Chairman/Independent Director
Elizabeth Mora
President/Chief Executive Officer/Director
Nabil Shabshab
Chief Financial Officer/Executive Vice President/Treasurer
Kristin Caltrider
Executive Vice President/Chief Technology Officer
Stanislav Glezer
Executive Vice President/General Counsel/Secretary
Jason Somer
Executive Vice President
George Parr
Executive Vice President
Bart Sanford
Independent Director
Glenn Boehnlein
Independent Director
Kevin King
Independent Director
Mary Ladone
Independent Director
Kristen Miranda
Independent Director
Heather Rider
No Data
No Data
About INGN
Inogen, Inc. is a medical technology company that develops, manufactures and markets portable oxygen concentrators (POCs). Its POCs is used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a single battery. Its product offering includes Inogen One G5, Inogen One G4, and Inogen One G3, for long-term oxygen therapy. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology from which the patient receives a bolus of oxygen upon inhalation. The Company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

Webull offers kinds of Inogen Inc stock information, including NASDAQ:INGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INGN stock methods without spending real money on the virtual paper trading platform.